ArticleFrontiers in pediatrics2020

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

Nerea Vega-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.